183 related articles for article (PubMed ID: 3061690)
1. Lack of complement activation by human IgA immune complexes.
Imai H; Chen A; Wyatt RJ; Rifai A
Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
Rifai A; Chen A; Imai H
Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of nephritogenic IgA immune complexes.
Rifai A
Am J Kidney Dis; 1988 Nov; 12(5):402-5. PubMed ID: 3189324
[TBL] [Abstract][Full Text] [Related]
4. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
[TBL] [Abstract][Full Text] [Related]
5. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
Montinaro V; Esparza AR; Cavallo T; Rifai A
Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
[TBL] [Abstract][Full Text] [Related]
6. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
[TBL] [Abstract][Full Text] [Related]
7. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
Emancipator SN; Ovary Z; Lamm ME
Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
[TBL] [Abstract][Full Text] [Related]
8. Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
Pfaffenbach G; Lamm ME; Gigli I
J Exp Med; 1982 Jan; 155(1):231-47. PubMed ID: 7054357
[TBL] [Abstract][Full Text] [Related]
9. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
10. Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.
Rifai A; Millard K
Clin Exp Immunol; 1985 May; 60(2):363-8. PubMed ID: 3891168
[TBL] [Abstract][Full Text] [Related]
11. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
[TBL] [Abstract][Full Text] [Related]
12. Circulating and deposited immune complexes in patients with glomerular disease: immunopathologic correlations.
Stachura I; Whiteside TL; Kelly RH
Am J Pathol; 1981 Apr; 103(1):21-30. PubMed ID: 6908818
[TBL] [Abstract][Full Text] [Related]
13. Mixed IgA-IgG aggregates as a model of immune complexes in IgA nephropathy.
Waldo FB; Cochran AM
J Immunol; 1989 Jun; 142(11):3841-6. PubMed ID: 2715639
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
Zhang W; Lachmann PJ
Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
[TBL] [Abstract][Full Text] [Related]
15. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
[TBL] [Abstract][Full Text] [Related]
16. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
Chen A; Wong SS; Rifai A
Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
[TBL] [Abstract][Full Text] [Related]
17. Experimental IgA nephropathy.
Rifai A; Small PA; Teague PO; Ayoub EM
J Exp Med; 1979 Nov; 150(5):1161-73. PubMed ID: 159331
[TBL] [Abstract][Full Text] [Related]
18. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
Zheng F; Kundu GC; Zhang Z; Ward J; DeMayo F; Mukherjee AB
Nat Med; 1999 Sep; 5(9):1018-25. PubMed ID: 10470078
[TBL] [Abstract][Full Text] [Related]
19. The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition.
Ma Y; Chen L; Xu Y; Han Q; Yu B; Zhao J; Hua Z; Yang Y; Chen J; Han F
Appl Immunohistochem Mol Morphol; 2020; 28(10):e87-e93. PubMed ID: 31789820
[TBL] [Abstract][Full Text] [Related]
20. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
